[1] Ali, A.; Sheylan, P.; Jessica, C. Pulmonary arterial hypertension and associated conditions. Dis. Mon. 2016, 62, 382-405.
[2] Hoeper, M.; Humbert, M.; Souza, R. A global view of pulmonary hypertension. Lancet Respiratory Medicine. 2016, 4, 22.
[3] Anton, V..; Joanne, A..; Harm, J.B. Pulmonary hypertension. Eur. Respir. Rev. 2016, 25, 4-11.
[4] Yuebin, G.; Zhigang, W.; Ying, X. Anti-inflammatory and blood stasis activities of essential oil extracted from Artemisia argyi leaf in animals. J. Nat. Med. 2016, 70, 1-8.
[5] Monge, C.; León-Velarde, F. Physiological adaptation to high altitude: Oxygen transport in mamals and birds. Physiol. Rev. 1991,71, 1135-1172.
[6] Julian, R.J.; Caston, L.J.; Leeson, S. The effect of dietary sodium on right ventricular failure-induced ascites, gain and fat deposition in meat-type chickens. Canadian J. Vet. Res. 1992, 56, 214-219.
[7] Wei, B.; Du, J.; Qi, J. L-arginine impacts pulmonary vascular structure in rats with an aortocaval shunt. J. Surg. Res. 2002, 108, 20-31.
[8] Voelkel, N.F.; Cool, C.; Lee S.D.; Wright, L.; Geraci, M.W.; Tuder, R.M. Primary pulmonary hypertension between inflammation and cancer. Chest. 1998, 114, 225-230.
[9] Iwasaki, T.; Takahashi, T.; Shimizu, H. Increased pulmonary heme oxygenase-1 and delta-aminolevulinate synthase expression in monocrotaline induced pulmonary hypertension. Curr. Neurovascular Res. 2005, 2, 133-139.
[10] Enomoto, A.; Kimura, H.; Chairoungdua, A. Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature. 2002, 417, 447-452.
[11] Kevin, B.M.; James, R.K.; Sharon, I.S.R. Pulmonary arterial hypertension: new insights and new hope. Respirology. 2006, 11, 6-17.
[12] Ralph, T.S.; Hossein, A.G.; Martin, R.W. Mechanisms of disease: pulmonary arterial hypertension. Nature Rev. Cardiology. 2011, 8, 443-455.
[13] Zaiman, A.; Fijalkowska, I.; Hassoun, P.M. One Hundred Years of Research in the Pathogenesis of Pulmonary Hypertension. Am. J. Respir. Cell Mol. Biol. 2005, 33, 425-431.
[14] St.fano, A.D.; Caramori, G.; Oates, T. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur. Respir. J. 2002, 20, 556-563.
[15] Sen, R.; Baltimore, D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986, 46, 705-716.
[16] Blackwell, T.S.; Christman, J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell & Mol. Biol. 1997, 17, 3-9.
[17] Christman, J.W.; Sadikot, R.T.; Blackwell, T.S. The role of nuclear factor-kappa B in pulmonary diseases. Chest. 2000, 1482-1487.
[18] Wright, J.G.; Christman, J.W. The Role of Nuclear Factor Kappa B in the Pathogenesis of Pulmonary Diseases: Implications for Therapy. Treat. Respir. Med. 2003, 211-219.
[19] Muraoka, K.; Shimizu, K.; Sun, X. Hypoxia, but not reoxygenation, induces interleukin 6 gene expression through NF-kappa B activation. Transplantation. 1997, 63, 466-470.
[20] Ao, Q.; Xiong, M.; Hao, C. Changes of NF-κB and P53 during Hypoxic Pulmonary Arterial Smooth Muscle Cell Proliferation and Apoptosis. Acta Univ. Med. Tongji. 2002.
[21] Jiménez-Garza, O.; Camacho, J.; Ibarra, A. Early Effects of Modulating Nuclear Factor-κB Activation on Traumatic Spinal Cord Injury in Rats. Ann. NY Acad. Sci. 2005, 1053, 148-150.
[22] Mamoru, O.; Masanori, T.; Masato, S. The role of nuclear factor-kappa B in the regulation of endothelin-1 production by nitric oxide. European J. Pharmacol. 2003, 472, 159-164.
[23] Mandy, W.; Elizabeth, G.W.; Sonya C.B. Role for Nuclear Factor-κB and Signal Transducer and Activator of Transcription 1/Interferon Regulatory Factor-1 in Cytokine-Induced Endothelin-1 Release in Human Vascular Smooth Muscle Cells. Mol. Pharmacol. 2003, 64, 923-931. |